Custom Health Holdings Inc.

As of June 30, 2026, Custom Health Holdings Inc. carries a market capitalization of 213.00M, placing it among publicly traded companies globally. Its enterprise value stands at 260.42M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Custom Health Holdings Inc.'s next confirmed earnings release is scheduled for December 2, 2026.

As of June 30, 2026, Custom Health Holdings Inc. has 25.85M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Custom Health Holdings Inc. maintains a current ratio of 0.16, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -123.06, indicating conservative leverage, while an interest coverage ratio of -1.73 demonstrates limited ability to service its debt obligations.

These figures are as of the close on October 22, 2026.

These figures cover the twelve months ended June 30, 2026.

As of June 30, 2026, Custom Health Holdings Inc. holds 1.55M in cash and equivalents against 48.96M in total debt, resulting in a net debt position of 40.79M. Total book value stands at -39.79M, with working capital of -61.11M providing operational flexibility.

Over the twelve months ended June 30, 2026, Custom Health Holdings Inc. posted a gross margin of 39.29, reflecting its pricing power and cost economics. The operating margin of -105.48 and net profit margin of -452.26 provide insight into operational efficiency.